Applied Total Assets vs Total Stockholder Equity Analysis

APDN Stock  USD 0.22  0.02  10.00%   
Applied DNA financial indicator trend analysis is way more than just evaluating Applied DNA Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Applied DNA Sciences is a good investment. Please check the relationship between Applied DNA Total Assets and its Total Stockholder Equity accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Total Assets vs Total Stockholder Equity

Total Assets vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Applied DNA Sciences Total Assets account and Total Stockholder Equity. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Applied DNA's Total Assets and Total Stockholder Equity is 0.87. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Applied DNA Sciences, assuming nothing else is changed. The correlation between historical values of Applied DNA's Total Assets and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Applied DNA Sciences are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Total Assets i.e., Applied DNA's Total Assets and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.87
Relationship DirectionPositive 
Relationship StrengthStrong

Total Assets

Total assets refers to the total amount of Applied DNA assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Applied DNA Sciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
Most indicators from Applied DNA's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Applied DNA Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
As of the 14th of December 2024, Selling General Administrative is likely to drop to about 10 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 10.3 M
 2021 2022 2023 2024 (projected)
Total Revenue18.2M13.4M15.4M16.1M
Research Development3.9M3.7M4.3M4.5M

Applied DNA fundamental ratios Correlations

0.43-0.710.83-0.530.380.390.720.73-0.530.650.69-0.440.590.590.580.410.560.530.580.580.340.390.48-0.460.32
0.43-0.430.62-0.20.240.110.430.27-0.20.780.87-0.850.760.760.90.040.480.320.680.540.010.480.36-0.650.69
-0.71-0.43-0.70.26-0.51-0.5-0.93-0.670.26-0.7-0.650.46-0.57-0.57-0.57-0.51-0.57-0.61-0.68-0.64-0.13-0.17-0.550.63-0.17
0.830.62-0.7-0.350.320.30.630.59-0.340.760.76-0.630.670.670.780.270.480.50.630.560.170.440.41-0.40.48
-0.53-0.20.26-0.35-0.2-0.14-0.29-0.341.0-0.42-0.320.05-0.15-0.15-0.220.26-0.39-0.08-0.44-0.3-0.22-0.28-0.290.35-0.22
0.380.24-0.510.32-0.20.860.70.79-0.180.60.58-0.430.60.60.29-0.060.77-0.030.760.83-0.430.20.97-0.3-0.3
0.390.11-0.50.3-0.140.860.690.91-0.130.460.55-0.410.60.60.280.00.710.230.650.62-0.240.220.86-0.29-0.3
0.720.43-0.930.63-0.290.70.690.8-0.290.710.72-0.460.630.630.510.440.760.520.770.750.00.290.74-0.650.08
0.730.27-0.670.59-0.340.790.910.8-0.330.630.7-0.50.70.70.470.150.770.410.730.71-0.020.330.84-0.39-0.09
-0.53-0.20.26-0.341.0-0.18-0.13-0.29-0.33-0.41-0.310.04-0.14-0.14-0.210.26-0.38-0.08-0.43-0.29-0.23-0.28-0.280.35-0.22
0.650.78-0.70.76-0.420.60.460.710.63-0.410.9-0.820.840.840.84-0.020.610.370.920.84-0.120.290.71-0.610.35
0.690.87-0.650.76-0.320.580.550.720.7-0.310.9-0.880.920.920.90.110.740.440.870.76-0.010.520.69-0.680.46
-0.44-0.850.46-0.630.05-0.43-0.41-0.46-0.50.04-0.82-0.88-0.96-0.96-0.93-0.02-0.39-0.35-0.68-0.630.18-0.21-0.520.41-0.35
0.590.76-0.570.67-0.150.60.60.630.7-0.140.840.92-0.961.00.880.110.550.40.750.74-0.210.250.68-0.420.2
0.590.76-0.570.67-0.150.60.60.630.7-0.140.840.92-0.961.00.880.110.550.40.750.74-0.210.250.68-0.420.2
0.580.9-0.570.78-0.220.290.280.510.47-0.210.840.9-0.930.880.880.070.40.450.690.590.090.320.42-0.560.58
0.410.04-0.510.270.26-0.060.00.440.150.26-0.020.11-0.020.110.110.070.070.46-0.12-0.020.180.05-0.11-0.160.04
0.560.48-0.570.48-0.390.770.710.760.77-0.380.610.74-0.390.550.550.40.070.290.810.71-0.120.710.82-0.630.14
0.530.32-0.610.5-0.08-0.030.230.520.41-0.080.370.44-0.350.40.40.450.460.290.320.270.220.160.15-0.40.27
0.580.68-0.680.63-0.440.760.650.770.73-0.430.920.87-0.680.750.750.69-0.120.810.320.89-0.130.420.86-0.680.27
0.580.54-0.640.56-0.30.830.620.750.71-0.290.840.76-0.630.740.740.59-0.020.710.270.89-0.290.160.91-0.420.0
0.340.01-0.130.17-0.22-0.43-0.240.0-0.02-0.23-0.12-0.010.18-0.21-0.210.090.18-0.120.22-0.13-0.290.17-0.37-0.350.56
0.390.48-0.170.44-0.280.20.220.290.33-0.280.290.52-0.210.250.250.320.050.710.160.420.160.170.25-0.540.55
0.480.36-0.550.41-0.290.970.860.740.84-0.280.710.69-0.520.680.680.42-0.110.820.150.860.91-0.370.25-0.39-0.18
-0.46-0.650.63-0.40.35-0.3-0.29-0.65-0.390.35-0.61-0.680.41-0.42-0.42-0.56-0.16-0.63-0.4-0.68-0.42-0.35-0.54-0.39-0.61
0.320.69-0.170.48-0.22-0.3-0.30.08-0.09-0.220.350.46-0.350.20.20.580.040.140.270.270.00.560.55-0.18-0.61
Click cells to compare fundamentals

Applied DNA Account Relationship Matchups

Applied DNA fundamental ratios Accounts

201920202021202220232024 (projected)
Total Current Liabilities4.3M3.3M4.2M2.8M3.3M3.9M
Total Stockholder Equity5.7M11.1M12.9M5.0M5.7M6.0M
Retained Earnings(269.8M)(284.1M)(292.5M)(302.4M)(272.2M)(258.6M)
Accounts Payable1.3M1.4M1.7M1.1M1.2M892.3K
Common Stock Shares Outstanding196.0K345.9K448.4K653.8K751.8K789.4K
Non Current Liabilities Total1.4M31.5K5.2M5.9M6.8M7.2M
Other Stockholder Equity275.5M295.2M305.4M307.4M353.5M371.2M
Total Liab5.6M3.3M9.4M8.8M10.1M10.6M
Common Stock5.1K7.5K12.9K13.7K12.3K11.7K
Other Current Liab676.4K1.6M1.9M1.2M1.1M1.1M
Total Assets11.3M14.4M22.3M13.7M15.7M16.5M
Net Debt(5.4M)(6.6M)(15.2M)(5.9M)(5.3M)(5.1M)
Cash7.8M6.6M15.2M7.2M8.2M8.6M
Cash And Short Term Investments7.8M6.6M15.2M7.2M8.2M8.6M
Liabilities And Stockholders Equity11.3M14.4M22.3M13.7M15.7M16.5M
Total Current Assets9.1M11.3M19.9M8.1M9.3M5.0M
Non Current Assets Total2.3M3.1M2.3M5.5M6.4M6.7M
Intangible Assets864.2K734.8K605.3K2.7M2.4M2.6M
Property Plant And Equipment Net1.3M3.0M2.2M2.1M2.4M2.5M
Current Deferred Revenue511.0K281K563.6K76.4K68.8K65.4K
Non Currrent Assets Other95.1K95.0K99.0K750K862.5K905.6K
Property Plant And Equipment Gross1.3M3.8M4.3M5.5M6.3M6.6M
Net Receivables194.3K2.8M3.1M255.5K293.8K279.1K
Other Current Assets1.2M1.1M2.1M389.2K447.6K509.6K
Net Tangible Assets(1.9M)4.8M11.1M12.9M14.8M15.6M
Property Plant Equipment226.2K1.3M3.0M2.2M2.6M2.7M
Other Assets172.0K95.1K95.0K99.0K89.1K84.6K
Inventory497.4K1.4M602.2K330.0K379.5K347.2K
Other Liab622.0K848.3K31.5K5.2M5.9M6.2M

Pair Trading with Applied DNA

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Applied DNA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied DNA will appreciate offsetting losses from the drop in the long position's value.

Moving against Applied Stock

  0.87JBL Jabil CircuitPairCorr
  0.8HPE Hewlett Packard EntePairCorr
  0.75CLS Celestica Buyout TrendPairCorr
  0.74ZBRA Zebra TechnologiesPairCorr
  0.73MSI Motorola SolutionsPairCorr
The ability to find closely correlated positions to Applied DNA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Applied DNA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Applied DNA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Applied DNA Sciences to buy it.
The correlation of Applied DNA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Applied DNA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Applied DNA Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Applied DNA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Applied DNA Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Applied DNA's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Applied Dna Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Applied Dna Sciences Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.53)
Revenue Per Share
2.202
Quarterly Revenue Growth
(0.73)
Return On Assets
(0.57)
Return On Equity
(0.76)
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.